I feel sorry for those selling at this level. Who knows, in the current unforgiving market they may have no choice. Hang in there if you can, I believe the pain is nearly over.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%